NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Operating cash flow, 2025
- DKK 119.1B
- YoY, 2025
- −1.5%
- 5-year CAGR
- +18.0%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | DKK 119.1B | −1.5% |
| 2024 | DKK 121.0B | +11.1% |
| 2023 | DKK 108.9B | +38.1% |
| 2022 | DKK 78.9B | +43.4% |
| 2021 | DKK 55.0B | +5.9% |
| 2020 | DKK 52.0B | +11.0% |
| 2019 | DKK 46.8B | — |